These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of two malignant melanomas during administration of levodopa. Przybilla B; Schwab U; Landthaler M; Braun-Falco O Acta Derm Venereol; 1985; 65(6):556-7. PubMed ID: 2420127 [TBL] [Abstract][Full Text] [Related]
3. Long-term effects of home-made levodopa in 43 cases of paralysis agitans. Liu D; Jiang Y Chin Med J (Engl); 1979 Nov; 92(11):807-10. PubMed ID: 116825 [No Abstract] [Full Text] [Related]
4. Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion. Meiler B; Andrich J; Müller T Mov Disord; 2008 Jan; 23(1):145-6. PubMed ID: 17987653 [TBL] [Abstract][Full Text] [Related]
5. Black cartilage after therapy with levodopa and methyldopa. Rausing A; Rosén U Arch Pathol Lab Med; 1994 May; 118(5):531-5. PubMed ID: 8192560 [TBL] [Abstract][Full Text] [Related]
13. Levodopa in the treatment of Parkinson's disease. Schapira AH; Emre M; Jenner P; Poewe W Eur J Neurol; 2009 Sep; 16(9):982-9. PubMed ID: 19538218 [TBL] [Abstract][Full Text] [Related]
14. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations. Sage JI; Mark MH Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688 [TBL] [Abstract][Full Text] [Related]
15. [Intravenous infusion of L-dopa: current prospective therapies]. Peppe A; De Angelis D; Tolli VS; Rizzo PA; Scoppetta C Riv Neurol; 1991; 61(5):197-200. PubMed ID: 1808680 [TBL] [Abstract][Full Text] [Related]
16. Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements. Montastruc JL; Celsis P; Agniel A; Demonet JF; Doyon B; Puel M; Marc-Vergnes JP; Rascol A Mov Disord; 1987; 2(4):279-89. PubMed ID: 3509776 [TBL] [Abstract][Full Text] [Related]
17. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa. Med Lett Drugs Ther; 2005 Jan; 47(1201):12. PubMed ID: 15706700 [TBL] [Abstract][Full Text] [Related]
18. [A year of treatment with carbidopa and levodopa in Parkinsonian patients]. Martínez-Lage JM; Marti-Massó JF; Delgado G; Carreray N; Del Amo F Rev Clin Esp; 1974 Sep; 134(6):535-42. PubMed ID: 4450036 [No Abstract] [Full Text] [Related]